Stockreport

4DMT Reports First Quarter 2024 Financial Results and Operational Highlights [Yahoo! Finance]

4D Molecular Therapeutics, Inc.  (FDMT) 
PDF Interim 24-week landmark analysis from PRISM Phase 2 Population Extension cohort evaluating 4D-150 in broader wet AMD population expected to be presented at the America [Read more]